Strategic Middle EAST Neurological Disorder Drug Market Analysis: Competitive Landscape of the Global Industry
The Middle EAST Neurological Disorder Drug Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 7.2 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of neurological disorders, increased healthcare spending, and advancements in drug development technologies. The region is witnessing a surge in demand for effective treatment options for conditions such as depression, schizophrenia, and epilepsy, which are becoming increasingly common. According to the World Health Organization (WHO), the incidence of neurological disorders is on the rise, with an estimated 1 in 6 individuals affected by mental health issues, highlighting the urgent need for effective pharmacological interventions. The global Middle EAST Neurological Disorder Drug market is highly consolidated due to the presence of a large number of companies across this industry. Also, they control a considerable portion o...